0000921895-21-001335.txt : 20210514
0000921895-21-001335.hdr.sgml : 20210514
20210514163910
ACCESSION NUMBER: 0000921895-21-001335
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210512
FILED AS OF DATE: 20210514
DATE AS OF CHANGE: 20210514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUGGAN ROBERT W
CENTRAL INDEX KEY: 0001055919
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 21925347
MAIL ADDRESS:
STREET 1: 611 SOUTH FORT HARRISON AVE
STREET 2: SUITE 306
CITY: CLEARWATER
STATE: FL
ZIP: 33756
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-514-7149
MAIL ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
form412566dug_05142021.xml
OWNERSHIP DOCUMENT
X0306
4
2021-05-12
0
0001599298
Summit Therapeutics Inc.
SMMT
0001055919
DUGGAN ROBERT W
611 SOUTH FORT HARRISON AVE
SUITE 306
CLEARWATER
FL
33756
1
1
1
0
Chief Executive Officer
Common Stock
2021-05-12
4
P
0
11365921
5.24
A
67662454
D
Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.
/s/ Michael Paul Donaldson, Attorney-in-Fact
2021-05-14